Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
62.11
+6.24 (11.17%)
At close: Mar 9, 2026, 4:00 PM EDT
62.07
-0.04 (-0.06%)
After-hours: Mar 9, 2026, 7:02 PM EDT

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
66931711926105
Upgrade
Market Cap Growth
278.64%437.50%-85.46%361.35%-75.29%-81.46%
Upgrade
Enterprise Value
1184-3916-5819
Upgrade
Last Close Price
55.8787.1131.50219.7582.31334.50
Upgrade
PS Ratio
46.53-3.5311.82--
Upgrade
PB Ratio
5.852.190.601.560.380.94
Upgrade
P/TBV Ratio
1.392.190.601.560.380.94
Upgrade
EV/Sales Ratio
---1.62--
Upgrade
Debt / Equity Ratio
0.010.010.100.060.090.06
Upgrade
Net Debt / Equity Ratio
-1.14-1.14-1.25-1.20-1.06-0.74
Upgrade
Net Debt / EBITDA Ratio
1.331.330.641.771.541.96
Upgrade
Net Debt / FCF Ratio
1.461.460.642.761.752.29
Upgrade
Asset Turnover
--0.070.11--
Upgrade
Quick Ratio
4.854.852.543.946.3510.03
Upgrade
Current Ratio
5.175.172.904.186.7210.36
Upgrade
Return on Equity (ROE)
-109.24%-109.24%-100.70%-66.10%-51.35%-32.43%
Upgrade
Return on Assets (ROA)
-46.46%-46.46%-47.06%-34.28%-27.86%-18.17%
Upgrade
Return on Capital Employed (ROCE)
-85.00%-85.00%-187.40%-65.40%-64.60%-35.80%
Upgrade
Earnings Yield
-65.97%-41.79%-305.73%-40.17%-178.61%-40.41%
Upgrade
FCF Yield
-56.42%-35.74%-322.61%-27.90%-161.25%-34.37%
Upgrade
Buyback Yield / Dilution
-39.34%-39.33%-7.15%-63.68%-0.71%-289.93%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.